DLF Results Update

DLF Earnings Call Transcript: Key Takeaways

DLF delivered a robust quarter with consolidated revenue of ₹2,298 Cr, significantly bolstered by a ₹738 Cr one-time gain. The narrative centers on a successful luxury sell-out and a strategic transition toward long-term rental income.

DLF Investor Presentation: Key Takeaways

DLF delivered strong Q2FY27 performance with sales bookings of INR 3,800 cr and collections of INR 2,780 cr. The group maintains a robust net cash position of INR 15,084 cr.

DLF Results Update

DLF Limited reported consolidated revenue of Rs 2,298 crore and a net profit of Rs 1,301 crore for Q2FY27, supported by strong operating cash flows.

DLF Promoter Reclassification

DLF Limited's board approved the reclassification of Madhukar Housing and Development Company from 'Promoter' to 'Public' category, subject to stock exchange approval.

DLF Q2 FY27 Results: Net Profit ₹1,301 Cr, Up 10.3% YoY

DLF Ltd reported revenue from operations of ₹1,261 Cr (-23.3% YoY) and net profit of ₹1,301 Cr (+10.3% YoY) for Q2 FY27.

Key figure

Net profit ₹1,301 Cr · +10.3% YoY

DLF Board Meeting Date

DLF Limited scheduled a board meeting for October 16, 2026, to consider and approve the standalone and consolidated financial results for the half-year ended September 2026.

Indostar Capital Finance Results Update

IndoStar reported Q2 FY27 standalone results, with disbursements up 51% YoY to ₹1,399 crore. Profit after tax rose to ₹13.1 crore and AUM reached ₹8,459 crore.

Alivus Life Sciences Results Update

Alivus Life Sciences reported Q2FY27 revenue of Rs. 6,820 Mn (up 16.0% YoY) and PAT of Rs. 1,968 Mn in a press release. Investors see record EBITDA margins of 41.8% and capex progress at Solapur and Taloja.

Asset Reconstruction Company (India) Results Update

ARCIL's H1FY27 release shows total income up 48% to Rs.516.4 crore and PAT up 54% to Rs.290.0 crore. Investors should view performance over a longer horizon.

Capital Small Finance Bank Results Update

Capital SFB's Q2 FY27 PAT rose 30.7% year-on-year to ₹45.61 crore, while advances grew 23.4%. Asset quality improved, with GNPA at 2.36% and NNPA at 1.12%.

Strides Pharma Science Results Update

Strides Pharma reported Q2FY27 revenue of ₹14,297m, up 17.1% YoY, and EBITDA of ₹2,509m, up 8.4%, in a press release. Reported PAT rose 2.0% to ₹1,341m.

Fiberweb (India) Results Update

Fiberweb India's Q2 FY27 press release shows total income of ₹30.99 crore, up 209.36% quarter-on-quarter. Net profit rose to ₹1.27 crore.